相关实验视频

Updated: Jan 6, 2026

Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis

Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis

Published on: October 18, 2024

艾普雷米拉斯特与安慰剂对于女性的生殖器侵蚀性平:随机对照试验

Kristin Helene Skullerud¹, Petter Gjersvik², Are Hugo Pripp³

¹Norwegian Research Centre for Women's Health, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Norway.

Journal of lower genital tract disease

|October 14, 2025

概括

在女性中,阿普雷米拉斯特对中度至重度的生殖器侵蚀性平坦 (GELP) 没有显著的临床影响. 与安慰剂相比,这项随机试验没有发现GELP得分或生活质量指标的改善.

科学领域:

皮肤病学皮肤病学
临床药理学临床药理学
免疫学免疫学免疫学

背景情况:

生殖器侵蚀性平坦 (GELP) 是一种慢性炎症疾病,影响女性.
目前对GELP的治疗有局限性,需要探索新型治疗剂.
固酶-4 (PDE4) 抑制剂,如阿普雷米拉斯,调节炎症通路,并可能提供一种新的治疗选择.

研究的目的:

为了评估apremilast在中度至重度GELP的妇女中的疗效和安全性.
评估阿普雷米拉斯特对GELP患者临床症状和生活质量的影响.

主要方法:

一个随机,双盲,安慰剂对照试验,涉及37名中度至重度GELP的妇女.
参与者每天两次接受30毫克的阿普雷米拉斯特或安慰剂,持续24周.
使用GELP得分来衡量有效性,其次要终点包括女性性痛苦量表修订和皮肤病学生活质量指数.

主要成果:

在24周后,在阿普雷米拉斯和安慰剂组之间没有观察到平均GELP得分的显著差异 (p = .71).
二次结果测量,包括性困扰和生活质量,同样没有显示出与apremilast显著改善.
在这两组中都报告了不良事件,在两名接受apremilast的妇女中发生了严重的不良事件.

结论:

这项随机对照试验没有证明阿普雷米拉斯特对女性中度至重度GELP的临床益处.
这项研究表明,尽管阿普雷米拉斯特具有抗炎性质,但它对这种情况并不有效.
用更大的样本大小进行进一步的研究可能是有必要的,但目前的发现表明GELP治疗中apremilast的潜力有限.

关键词:

临床试验,随机的临床试验.类平坦的类.二-4酶抑制剂的使用系统性治疗是全身疗法.阴道阴道阴道阴道阴道阴道阴道

更多相关视频

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

相关概念视频

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...